I apologize for not posting more here at HWC; I recently traveled to Iowa City to undergo a stem cell transplant at the University of Iowa Cancer Center.
The researchers involved call this breakthrough a “game-changer for drug development.” The applications in oncology are countless:
Good news. $10,000,000 can make a real difference when its focused like this. I can’t think of a more important area to research.
The FDA just approved yet another new, late stage melanoma therapy, nivolumab. That makes a record, mind blowing seven new FDA approved drugs since 2011.
Easy to follow explanation for why drug prices are so high in United States as compared to other countries. Here are several excerpts from this important Medscape Today article:
If only other cancers could feature ample breasts–without impunity–in their fundraising and informational pieces! My bias exposed, this Fox News report does feature some great suggestions. I’ve included a copy of the opening picture to help make my point:
This is exciting news. Not so much because of this specific new drug. But because of what it represents: cancer immunotherapy is becoming a reality.
This unfortunate turn of events mirrors the real world: over 230,000 American women are expected to be diagnosed with breast cancer by year’s end:
I work so hard every single day just to stay alive–it drives me crazy when I see someone smoking or overeating. Add smokeless tobacco to the list.
Stories like this aren’t new. Aside from the human interest angle, maybe there’s a way to really use dog’s abilities to sniff out cancer:
Did you catch the story about how fruit flies may hold the key to a cure for cancer? It’s all about individualized medicine. By growing tumors in fruit flies that are genetically identical to the patient’s, researchers can then test all currently available drugs ahead of time, identifying combinations that no one could ever hope to anticipate.
Check this out this excerpt from a Web MD article last week:
Check out this excerpt from an awesome George Johnson column in the New York Times yesterday:
On the surface, this headline sounds encouraging. But don’t forget to read the fine print:
Here’s some potentially good news for postmenopausal women at risk for developing breast cancer:
Immunotherapies have been hot topics at the last two ASH and ASCO conferences. That trend didn’t let up at this year’s American Society of Hematology annual meeting in New Orleans.
New targeted therapy options headlined this year’s American Society of Hematology meetings in New Orleans this year. One example: new drugs for chronic lymphocytic leukemia (CLL) that are more effective and better tolerated.
Breast cancer is always in the news. Here’s a pair of links from a website called FoodConsumer.org, touting supplements as a way to prevent it. See what you think:
I’ve always been an Amy Robach fan. As a lifelong Today Show viewer, I felt NBC made a mistake not giving her the co-anchor spot next to Matt Lauer a half dozen years ago. Passed over, Amy left for a new opportunity with ABC’s Good Morning America. This week viewers learned that Amy had been diagnosed with breast cancer.